Navigation Links
Ambiguity In Patent Laws May Defer New Drug Launches

Indian Government has refused to grant product patent for Glivec, the cancer drug from Novartis AG, the Swiss pharma giant. As a result Novartis may not be able to conduct// their drug research here in India. Singapore and China are the countries where Novartis conducts its research now.

While talking on this issue, Paul Herrling, who heads Corporate Research division of Novartis reveals that this decision by the Indian government could hamper the launch of their patented products. But this in any way will not affect the distribution of Glivec here. According to him, Novartis through its foundation has been distributing Glivec to needy patients to the tune of 1270 crore in India.

Trade analysts opine that if such drugs are not available freely in the market and are being prescribed by the physicians and supplied by a few pharmacies, it would prove to be very expensive to the patients.

Herrling feels that the primary objective of any drug company should be to improve health care services. They should focus their research on this area. Product patent alone is not sufficient but data individuality is more important.
JYT
'"/>




Page: 1

Related medicine news :

1. Botched Abortions Trigger Concern Over Legal Ambiguity In Britain
2. Indian Government Keen On JE Vaccine Supply And Patenting Of Indian Medicine Formulations
3. HIV Patients Opposes Patenting Of AIDS Drug
4. Provigil Patent Extension Accorded To Cephalon
5. AIDS Sufferers Protest against Proposed Patent for Tenofovir
6. POLY Medicure Ltd Applies for 8 Patents, 2 FDA Approvals
7. Venus Remedies Files 5th International Patent Application
8. US Court Rules Against Lupin in Ramipril Patent Case
9. Patent for Seminal RNAi innovation Cleared in Australia
10. Canada: On Popular Demand, Tamiflu finds a Berth in the Directory of Patent Drugs
11. Compellis Pharmaceuticals Gets Patent for Obesity-Fighting Nasal Spray CP404
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/27/2016)... NY (PRWEB) , ... June 27, 2016 , ... ... using cutting edge technology to revolutionize the emergency ambulance transport experience for the ... are aware of how Uber has disrupted the taxi industry through the use ...
(Date:6/26/2016)... ... 2016 , ... Pixel Film Studios Released ProSlice Levels, a Media Slicing Effect ... videos a whole new perspective by using the title layers in ProSlice Levels ... , ProSlice Levels contains over 30 Different presets to choose from. FCPX ...
(Date:6/25/2016)... ... June 25, 2016 , ... Experts from the American ... Annual Research Meeting June 26-28, 2016, at the Hynes Convention Center in Boston. ... including advance care planning, healthcare costs and patient and family engagement. , AIR ...
(Date:6/25/2016)... ... ... First Choice Emergency Room , the largest network of independent freestanding emergency ... its new Mesquite-Samuell Farm facility. , “We are pleased to announce Dr. Ogunleye ... M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. , Dr. Ogunleye ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits of moderation, ... the latter, setting the bar too high can result in disappointment, perhaps even self-loathing. ... toward their goal. , Research from PsychTests.com reveals that behind the ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... , June 23, 2016 Research and ... Global Market - Forecast to 2022" report to their ... treatment method for the patients with kidney failure, it replaces ... fluid from the patient,s blood and thus the treatment helps ... and chloride in balance. Increasing number of ...
(Date:6/23/2016)...  In a startling report released today, National Safety Council ... a comprehensive, proven plan to eliminate prescription opioid overdoses. ... states are tackling the worst drug crisis in recorded U.S. history, ... Kentucky , New Mexico , ... the 28 failing states, three – Michigan , ...
(Date:6/23/2016)... 2016 Capricor Therapeutics, Inc. ... biotechnology company focused on the discovery, development and ... enrollment in its ongoing randomized HOPE-Duchenne clinical trial ... of its 24-patient target. Capricor expects the trial ... of 2016, and to report top line data ...
Breaking Medicine Technology: